Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Axovant Sciences Ltd.

TRADE

NASDAQ: AXONHealthcare / Biotechnology / -
2.16-0.18-7.69%Vol 449 3631Y Perf -62.93%
Oct 19th, 2018 16:00
BID2.15 ASK2.33
Open2.36 Previous Close2.34
Pre-Market- After-Trading-
 - -%  - -%
Target Price
4.70 
Analyst Rating
Hold 2.67
Potencial %
117.59 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)264 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
20.47 
Earnings Date
1st Nov 2018

Today's Price Range

2.152.36

 

52wk Range

1.026.59

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
2.37%
3 Months
-12.20%
6 Months
100.00%
1 Year
-62.93%
3 Years
-83.05%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
AXON2.16-0.1800-7.69
AAPL219.313.29001.52
GOOG1 096.468.49000.78
MSFT108.660.16000.15
XOM81.970.12000.15
WFC52.89-0.2100-0.40
JNJ139.05-0.4500-0.32
FB154.05-0.8700-0.56
GE12.560.18001.45
JPM107.91-0.1800-0.17
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.20
Current Ratio 2.30
Long Term Debt to Total Capital 0.60
Total Debt to Equity 2.05
Interest Coverage -25.90
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 9.64
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -2.00
Cash Flow Per Share -1.89
Price to Tangible Book11.03
Book Value per Share0.21
Enterprise Value (in ths.)245 773
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -176.01
Return on Assets (5Y Avg) -
ROA last 12 Months -98.03
Return on Capital (5Y Avg) -
ROC last 12 Months -111.80
Return on invested Capital Q -49.22
Return on invested Capital Y-138.09
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.16-0.48-200.00
Q04 2018-0.35-0.2334.29
Q02 2018-0.55-0.64-16.36
Q01 2018-0.52-0.65-25.00
Q04 2017-0.51-0.53-3.92
Q03 2017-0.45-0.48-6.67
Q02 2017-0.40-0.43-7.50
Q01 2017-0.37-0.38-2.70
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.38-100.00Negative
12/2018 QR-0.35-66.67Negative
3/2019 FY-1.67-11.33Negative
3/2020 FY-1.35-51.69Negative
Next Report Date1st Nov 2018
Estimated EPS Next Report-0.38
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume449 363
Shares Outstanding (in ths.)122 080
Trades Count1 157
Dollar Volume952 474
Avg. Volume2 702 834
Avg. Weekly Volume1 078 609
Avg. Monthly Volume772 532
Avg. Quarterly Volume823 238

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

70%30%

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (16.67 %)
1 (16.67 %)
2 (28.57 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
5 (83.33 %)
5 (83.33 %)
5 (71.43 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
2.67
Hold
2.67
Moderate Buy
2.43

There are no comments yet.

News

x